Smaller solid lung cancers in asymptomatic patients are less likely than larger ones to have metastasized, with implications for a better prognosis, according to new research from the International Early Lung Cancer Action Program.
Smaller solid lung cancers in asymptomatic patients are less likely than larger ones to have metastasized, with implications for a better prognosis, according to new research from the International Early Lung Cancer Action Program.
Tumor size in relation to disease stage is an important prognostic indicator in lung cancer cases. The earlier tumors are found, with no metastases, the better the chances are for a cure.
Technical developments in CT technology have allowed researchers in the long-running I-ELCAP to apply submillimeter slicing across the chest in a single breath-hold as part of their lung cancer screening investigation. This advance has led to the discovery of smaller tumors.
Using the I-ELCAP data from nearly 29,000 patients in 38 institutions, researchers determined the number and types of cancers found, presence of metastases, and consistency of tumors (solid, nonsolid, or part-solid). Findings were published in the Feb. 13 issue of Archives of Internal Medicine.
Of the 464 cancers found in the total population studied, 436 were non-small cell carcinomas, which are less aggressive. On average, 85% of the non-small cell group had no metastases, but the researchers determined that cancer size was directly related to rate of metastases:
The finding that tumors were more likely to have metastases as they grew larger was particularly true for solid lesions but less true for part-solid lesions. The association did not exist for nonsolid lesions.
For more information from the DI archives:
Staging criteria for lung cancer face update
Report from RSNA: Survival data spur CT lung screening surge
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.